Form EFFECT OKYO Pharma Ltd
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 10, 2026 9:00 A.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OKYO Pharma Ltd. (OKYO) PT Lowered to $5 at H.C. Wainwright
- Peak Med Introduces PatientFlow OS, a Dental Marketing System for Clinics in Romania, the UK and the US
- Salus Scientific Welcomes Landmark Multi-Society Consensus Statement Advancing the Future of Occupational Radiation Safety
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
